Interventions for valvular disease
First-in-man use of the new-generation TriGUARD 3 cerebral embolic protection device during transcatheter aortic valve implantation December 7, 2018 | 10.4244/EIJ-D-18-00442
Showing 1-6 of 6 articles
Coronary interventions
Independent impact of extent of coronary artery disease and percutaneous revascularisation on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results December 7, 2018 | 10.4244/EIJ-D-18-00098
Interventions for valvular disease
To nurture a snake in one’s bosom: aspiration of a giant right atrium thrombus after a MitraClip procedure October 12, 2018 | 10.4244/EIJ-D-18-00411
Interventions for valvular disease
Combined erythropoietin and iron therapy for anaemic patients undergoing transcatheter aortic valve implantation: the EPICURE randomised clinical trial May 15, 2017 | 10.4244/EIJ-D-16-00591
Myocardial injury following transcatheter aortic valve implantation: insights from delayed-enhancement cardiovascular magnetic resonance
June 19, 2015 | 10.4244/EIJV11I2A39
Patient radiation exposure during transcatheter aortic valve replacement procedures
October 26, 2012 | 10.4244/EIJV8I6A106
